e.l.f. Beauty Releases FY2025 Impact Report with Emphasis on ‘ the Every ’
28.10.2025 05:01:00 CET | Business Wire | Press Release
e.l.f. Beauty (NYSE: ELF), a purpose-led, results-driven company on a mission to make the best of beauty accessible to every eye, lip and face, today released its fourth annual Impact Report.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251027352775/en/
e.l.f. Beauty releases 4th annual Impact Report, emphasizing it’s evolved purpose statement: to make the world a better place for every eye, lip and face.
The digital-first report is built around the theme of “the every”— a reflection of e.l.f.’s commitment to be a bold disruptor with a kind heart. To amplify the message behind the Impact Report, e.l.f. also launched a bold, international consumer campaign: “Give an e.l.f.” The campaign features voices of kindred spirits and encourages the community to fuel their own sense of purpose.
“Sharing our Impact Report is one of my proudest moments each year as we see the collective highlights of living our vision to be a different kind of company by building brands that disrupt norms, shape culture and connect communities through positivity, inclusivity and accessibility,” said Tarang Amin, Chairman and CEO, e.l.f. Beauty.
The report includes an evolution of the company’s purpose statement to emphasize action and impact: to make the world a better place for every eye, lip and face.
“Our commitment to show up as bold disruptors with kind hearts has been unwavering throughout the company’s 21-year history,” Amin said. “It guides how we operate each day and why we make every one of our choices as a purpose-led, results-driven company.”
e.l.f. Beauty’s strong ethos powers its purpose, purpose powers its people, people power its performance – and performance powers its possibilities. Focusing on achievements across key areas, including People & Culture, Innovation & Community, Campaigns & Activations, and Environment & Sustainability. Key highlights reported include:
- At least 2% of the prior year’s profits – totaling more than $2.5 million in FY2025 – donated to changemaking causes that align with the company’s values, spanning boardroom diversity, animal welfare, health and wellness, women's empowerment, LGBTQ+ advocacy, disaster relief and more
- More than 140 business leaders, nonprofits and peer companies have joined e.l.f. Beauty’s Change the Board Game coalition, all committed to creating more accessible boardrooms
- 75% of e.l.f. Cosmetics products are $10 and under to maximize accessibility
- 73% of e.l.f. Beauty brands’ products are made in Fair Trade Certified facilities*
- 100% of cosmetic brushes' wood handles now use Forest Stewardship Council™-certified wood*
- Achieved a 33% reduction in packaging intensity in FY2025 versus a 2019 baseline, exceeding our 2030 goal for a 20% reduction*
The complementary campaign, created with creative agency CASE, will be featured across social, digital, print and out-of-home placements with a simple, direct call to action: “What do you give an e.l.f. (F#@&) about?” Among those giving passionate and confident answers – straight to camera – are:
- Billie Jean King, equality champion, gives an e.l.f. about board diversity representation
- Aditya Madiraju, creator, gives an e.l.f. about LGBTQIA+ advocacy
- Jaedyn Shaw, professional soccer player, gives an e.l.f. about women in sports
- Kgothatso Montjane “KG”, paralympian, gives an e.l.f. about empowering.legendary.females.
- Amanda Nguyen, astronaut and activist, gives an e.l.f. about women’s rights
- Katherine Legge, professional racecar driver, gives an e.l.f. about putting girls in the driver’s seat
- Meduulla, musician, gives an e.l.f. about amplifying voices
- Melanie Barcenas, professional soccer player, gives an e.l.f. about self-expression
- Jess Rona, dog groomer, gives an e.l.f. about cruelty-free
- Javon Ford, cosmetic chemist, gives an e.l.f. about affordable skincare made with quality ingredients
- Paul Rice, founder of Fair Trade USA, gives an e.l.f. about Fair Trade
“We all give an e.l.f. We have the courage to care and that’s how we make the world a better place for every eye, lip and face,” said Kory Marchisotto, Chief Marketing Officer, e.l.f. Beauty. “This campaign is our collective voice calling the world to stand up, speak up and show up for what matters. It’s turning caring into a cultural movement. We’re force multiplying with icons like Billie Jean King and Amanda Nguyen to inspire everyone to take action on what they give an e.l.f. about.”
The campaign will appear across more than 40 digital screens in Moynihan Train Hall at New York’s Penn Station, and will be seen as a two-page spread in The New York Times on Sunday, November 2, 2025.
e.l.f. Beauty is also hosting a live activation today at 410 Lafayette Street in New York City from 10AM – 6PM ET, where the public is invited to “give an e.l.f.” — literally and figuratively. At a custom kiosk, visitors can select a cause they care about, and e.l.f. Beauty will make a donation to a nonprofit organization focused on that cause. Participating guests will receive a printed receipt confirming the donation and are invited to take their receipt to the gift bar in exchange for e.l.f. Beauty products.
To explore the full FY2025 Impact Report and learn more about how e.l.f. Beauty is creating change, visit: elfbeauty.com/impact.
Check out the campaign trailer here.
* These metrics do not include rhode, acquired in August 2025. Fair Trade metric is calculated on a unit basis.
About e.l.f. Beauty
e.l.f. Beauty (NYSE: ELF) is fueled by a belief that anything is e.l.f.ing possible. We are a different kind of company that disrupts norms, shapes culture and connects communities through positivity, inclusivity and accessibility. The mission is clear: to make the best of beauty accessible to every eye, lip and face. e.l.f. Beauty and its brands, e.l.f. Cosmetics, e.l.f. SKIN, Keys Soulcare, Well People, Naturium and rhode, are led by purpose, driven by results and elevated by superpowers, offering e.l.f. clean and vegan products. e.l.f. Beauty proudly stands as the first beauty company with Fair Trade Certified™ facilities. With a kind heart at the center of e.l.f.’s ethos, the company donates at least 2% of the prior year’s profits to organizations that make positive impacts. Learn more at www.elfbeauty.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20251027352775/en/
Contacts
Laura Cosgrave
lcosgrave@elfbeauty.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom